{
    "Trade/Device Name(s)": [
        "Liquichek Cardiac Markers Plus Control",
        "Liquichek Cardiac Markers Plus Control LT",
        "Liquichek Cardiac Markers Plus Control LT Low"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K050537",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040277"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "February 22, 2005",
    "Summary Letter Received Date": "March 2, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "B-type Natriuretic Peptide (BNP)",
        "Creatine Kinase, Total",
        "C-Reactive Protein (CRP)",
        "CK-MB Isoenzyme",
        "Digitoxin",
        "Homocysteine",
        "Myoglobin",
        "N-terminal pro-B-type Natriuretic Peptide (NT-pro BNP)",
        "Troponin I",
        "Troponin T"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        ""
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Cardiac Markers Plus Controls intended as quality control serum for cardiac marker testing in clinical laboratories.",
    "Indications for Use Summary": "Intended for use as a quality control serum to monitor the precision of laboratory testing procedures listed in the package insert.",
    "fda_folder": "Clinical Chemistry"
}